The Current Ratio as of December 2025 (TTM) for International Stem Cell Corporation (ISCO) is 0.80

According to International Stem Cell Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.80. This represents a change of 3.82% compared to the average of 0.77 of the last 4 quarters.

International Stem Cell Corporation (ISCO) Historical Current Ratio (quarterly & annually)

How has ISCO Current Ratio performed in the past?

The mean historical Current Ratio of International Stem Cell Corporation over the last ten years is 0.85. The current 0.80 Current Ratio has changed 9.32% with respect to the historical average. Over the past ten years (40 quarters), ISCO's Current Ratio was at its highest in in the December 2019 quarter at 1.80. The Current Ratio was at its lowest in in the March 2016 quarter at 0.19.

International Stem Cell Corporation (ISCO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of International Stem Cell Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

International Stem Cell Corporation (ISCO) Average Current Ratio

How has ISCO Current Ratio performed in the past?

The current Current Ratio of International Stem Cell Corporation (ISCO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

International Stem Cell Corporation (ISCO) Current Ratio vs. Peers

How is ISCO’s Current Ratio compared to its peers?

International Stem Cell Corporation’s Current Ratio is greater than Biocure Technology Inc. (0.11), greater than Evofem Biosciences, Inc. (0.10), less than Chia Tai Enterprises International Limited (1.51), greater than Marizyme, Inc. (0.03), greater than Biomind Labs Inc. (0.01), greater than Biora Therapeutics, Inc. (0.05), greater than NovelStem International Corp. (0.01), less than Unity Biotechnology, Inc. (0), less than DATATRAK International, Inc. (2.23), greater than Vaccinex, Inc. (0.50),

Build a custom stock screener for International Stem Cell Corporation (ISCO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like International Stem Cell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

International Stem Cell Corporation (ISCO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like International Stem Cell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.